NGNE
Neurogene Inc
31.30$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | 1.06 | – | – | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | |
| 0.01 | 0.01 | 0.01 | 0.02 | – | – | – | – | 0.01 | 0.04 | 0.77 | 0.25 | 0.25 | 0.18 | 0.15 | |
| -0.01 | -0.01 | -0.01 | -0.02 | – | – | – | 1.06 | -0.01 | -0.04 | -0.77 | -0.25 | -0.25 | -0.13 | -0.15 | |
| 0.85 | 0.59 | 0.75 | 2.07 | 1.25 | 1.50 | 1.55 | 1.39 | 0.23 | 0.47 | 0.77 | 3.70 | 3.46 | 3.47 | 3.54 | |
| – | – | – | – | – | – | – | – | – | – | 0.15 | 0.70 | 0.87 | 1.29 | 1.34 | |
| 1.03 | 0.75 | 0.93 | 2.57 | 1.69 | 1.99 | 2.18 | 2.06 | 0.89 | 0.77 | 0.15 | 4.16 | 4.08 | 4.57 | 4.72 | |
| -1.04 | -0.76 | -0.93 | -2.58 | -1.69 | -1.99 | -2.18 | -1.00 | -0.90 | -0.80 | -0.92 | -4.41 | -4.33 | -4.70 | -4.88 | |
| – | – | 0.00 | 0.26 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -1.06 | -0.76 | -0.87 | -2.77 | -1.73 | -1.96 | -2.14 | -1.34 | -2.57 | -0.64 | -0.92 | -4.30 | -2.83 | -4.28 | -4.27 | |
| -0.02 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | – | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | |
| -1.05 | -0.77 | -0.87 | -2.75 | -1.73 | -1.96 | -2.14 | -1.34 | -2.57 | -0.64 | -0.92 | -4.30 | -2.83 | -4.28 | -4.27 | |
| -1.05 | -0.75 | -0.86 | -2.50 | -1.72 | -1.96 | -2.14 | -1.34 | -2.56 | -0.61 | -0.90 | -4.05 | -2.57 | -4.09 | -4.12 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.